Key facts
- This page summarizes Daniel ShinYu Chen's Form 4 filing for IGM Biosciences, Inc. (IGMS).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 06 Jul 2021, 19:45.
Daniel ShinYu Chen - 01 Jul 2021 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- IGMS
- Reported as of
- 01 Jul 2021
- Net transaction value
- -$160,977
- SEC form
- 4
- Accepted by SEC
- 06 Jul 2021, 19:45:18 UTC
- Prior SEC filing
- 03 Jun 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Misbah Tahir, by power of attorney
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Daniel ShinYu Chen filed Form 4 for IGM Biosciences, Inc. (IGMS) on 06 Jul 2021.
Change
- Previous filing in this sequence was filed on 03 Jun 2021.
- Current net transaction value: -$160,977.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IGMS
transaction
Common Stock
Options Exercise
- Transaction value
- $2,641
- Shares
- +1,900
- Change %
- +1.6%
- Price
- $1.39*
- Shares after
- 118,418
- Date
- 01 Jul 2021
- Ownership
- Direct
- Footnotes
- F1
IGMS
transaction
Common Stock
Tax liability
- Transaction value
- $85,585
- Shares
- -957
- Change %
- -0.81%
- Price
- $89.43*
- Shares after
- 117,461
- Date
- 01 Jul 2021
- Ownership
- Direct
- Footnotes
- F2
IGMS
transaction
Common Stock
Sale
- Transaction value
- $78,033
- Shares
- -943
- Change %
- -0.8%
- Price
- $82.75*
- Shares after
- 116,518
- Date
- 06 Jul 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IGMS
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -1,900
- Change %
- -0.56%
- Price
- $0.000000
- Shares after
- 338,340
- Date
- 01 Jul 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,900
- Exercise price
- $1.39
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The option exercise and sale were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
Footnote F2
Represents shares withheld by the Issuer to pay the exercise price and taxes pursuant to the "net exercise" of 1,900 option shares.
Footnote F3
The option, originally for 361,090 shares, of which 22,750 shares have been exercised, vested as to 1/4 of the shares on August 1, 2019, and an additional 1/48 of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person remaining a service provider through each such date.